These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 16892196)

  • 21. Recent advances in positive allosteric modulators of the AMPA receptor.
    Morrow JA; Maclean JK; Jamieson C
    Curr Opin Drug Discov Devel; 2006 Sep; 9(5):571-9. PubMed ID: 17002217
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of non-competitive AMPA receptor antagonists injected into some brain areas of WAG/Rij rats, an animal model of generalized absence epilepsy.
    Citraro R; Russo E; Gratteri S; Di Paola ED; Ibbadu GF; Curinga C; Gitto R; Chimirri A; Donato G; De Sarro G
    Neuropharmacology; 2006 Nov; 51(6):1058-67. PubMed ID: 16901515
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The new 2,3-benzodiazepine derivative EGIS-8332 inhibits AMPA/kainate ion channels and cell death.
    Vegh MG; Kovács AD; Kovács G; Szabó G; Tihanyi K; Hársing LG; Lévay G
    Neurochem Int; 2007 Feb; 50(3):555-63. PubMed ID: 17147974
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Regulation of SULT2B1a (pregnenolone sulfotransferase) expression in rat C6 glioma cells: relevance of AMPA receptor-mediated NO signaling.
    Kohjitani A; Fuda H; Hanyu O; Strott CA
    Neurosci Lett; 2008 Jan; 430(1):75-80. PubMed ID: 18054434
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Synthesis and structure-activity relationships of 4,10-dihydro-4-oxo-4H-imidazo[1,2-a]indeno[1,2-e]pyrazine derivatives: highly potent and selective AMPA receptor antagonists with in vivo activity.
    Stutzmann JM; Vuilhorgne M; Mignani S
    Mini Rev Med Chem; 2004 Feb; 4(2):123-40. PubMed ID: 14965286
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Glutamatergic mechanisms in different disease states: overview and therapeutical implications -- an introduction.
    Tzschentke TM
    Amino Acids; 2002; 23(1-3):147-52. PubMed ID: 12373529
    [TBL] [Abstract][Full Text] [Related]  

  • 27. D-Serine inhibits AMPA receptor-mediated current in rat hippocampal neurons.
    Gong XQ; Zabek RL; Bai D
    Can J Physiol Pharmacol; 2007 May; 85(5):546-55. PubMed ID: 17632590
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The AMPA receptor positive allosteric modulator, S18986, is neuroprotective against neonatal excitotoxic and inflammatory brain damage through BDNF synthesis.
    Destot-Wong KD; Liang K; Gupta SK; Favrais G; Schwendimann L; Pansiot J; Baud O; Spedding M; Lelièvre V; Mani S; Gressens P
    Neuropharmacology; 2009 Sep; 57(3):277-86. PubMed ID: 19501111
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Synthesis and AMPA receptor antagonistic activity of a novel 7-imidazolyl-6-trifluoromethyl quinoxalinecarboxylic acid with a substituted phenyl group and improved its good physicochemical properties by introduced CF3 group.
    Takano Y; Shiga F; Asano J; Hori W; Anraku T; Uno T
    Bioorg Med Chem Lett; 2004 Oct; 14(20):5107-11. PubMed ID: 15380209
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The AMPA receptor binding site: focus on agonists and competitive antagonists.
    Stensbøl TB; Madsen U; Krogsgaard-Larsen P
    Curr Pharm Des; 2002; 8(10):857-72. PubMed ID: 11945136
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pentylenetetrazole-induced seizures affect binding site densities for GABA, glutamate and adenosine receptors in the rat brain.
    Cremer CM; Palomero-Gallagher N; Bidmon HJ; Schleicher A; Speckmann EJ; Zilles K
    Neuroscience; 2009 Sep; 163(1):490-9. PubMed ID: 19345722
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Synthesis and biological evaluation of novel 9-heteroaryl substituted 7-chloro-4,5-dihydro-4-oxo-1,2,4-triazolo[1,5-a]quinoxaline-2-carboxylates (TQX) as (R,S)-2-amino-3-(3-hydroxy-5-methylisoxazol-4-yl)propionic acid (AMPA) receptor antagonists.
    Catarzi D; Colotta V; Varano F; Filacchioni G; Gratteri P; Sgrignani J; Galli A; Costagli C
    Chem Pharm Bull (Tokyo); 2008 Aug; 56(8):1085-91. PubMed ID: 18670107
    [TBL] [Abstract][Full Text] [Related]  

  • 33. AMPA and NMDA receptor regulation of firing activity in 5-HT neurons of the dorsal and median raphe nuclei.
    Gartside SE; Cole AJ; Williams AP; McQuade R; Judge SJ
    Eur J Neurosci; 2007 May; 25(10):3001-8. PubMed ID: 17509083
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Rapid cortico-limbic alterations in AMPA receptor densities after administration of PCP: implications for schizophrenia.
    Zavitsanou K; Nguyen V; Newell K; Ballantyne P; Huang XF
    J Chem Neuroanat; 2008 Oct; 36(2):71-6. PubMed ID: 18640263
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Competitive Gly/NMDA receptor antagonists.
    Catarzi D; Colotta V; Varano F
    Curr Top Med Chem; 2006; 6(8):809-21. PubMed ID: 16719819
    [TBL] [Abstract][Full Text] [Related]  

  • 36. NR1 and GluR2 expression mediates excitotoxicity in chronic hypobaric hypoxia.
    Hota SK; Barhwal K; Singh SB; Sairam M; Ilavazhagan G
    J Neurosci Res; 2008 Apr; 86(5):1142-52. PubMed ID: 17969105
    [TBL] [Abstract][Full Text] [Related]  

  • 37. AMPA receptor antagonists for the treatment of stroke.
    Weiser T
    Curr Drug Targets CNS Neurol Disord; 2005 Apr; 4(2):153-9. PubMed ID: 15857300
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Neuroprotective effects of the AMPA antagonist PNQX in oxygen-glucose deprivation in mouse hippocampal slice cultures and global cerebral ischemia in gerbils.
    Montero M; Nielsen M; Rønn LC; Møller A; Noraberg J; Zimmer J
    Brain Res; 2007 Oct; 1177():124-35. PubMed ID: 17894933
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Structure-activity study of 2,3-benzodiazepin-4-ones noncompetitive AMPAR antagonists: identification of the 1-(4-amino-3-methylphenyl)-3,5-dihydro-7,8-ethylenedioxy-4H-2,3-benzodiazepin-4-one as neuroprotective agent.
    Micale N; Colleoni S; Postorino G; Pellicanò A; Zappalà M; Lazzaro J; Diana V; Cagnotto A; Mennini T; Grasso S
    Bioorg Med Chem; 2008 Mar; 16(5):2200-11. PubMed ID: 18083036
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Mechanism of inhibition of the GluR2 AMPA receptor channel opening by 2,3-benzodiazepine derivatives.
    Ritz M; Micale N; Grasso S; Niu L
    Biochemistry; 2008 Jan; 47(3):1061-9. PubMed ID: 18161947
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.